Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Clinical trial NCT02860819 · COMPLETED
Trial details
- NCT number
- NCT02860819
- Sponsor
- National Cancer Institute, Slovakia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-11-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.